Puma Biotechnology (PBYI)
(Real Time Quote from BATS)
$3.74 USD
+0.08 (2.19%)
Updated Jul 22, 2024 02:58 PM ET
4-Sell of 5 4
A Value A Growth C Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
PBYI 3.74 +0.08(2.19%)
Will PBYI be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for PBYI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PBYI
Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
Implied Volatility Surging for Puma Biotechnology (PBYI) Stock Options
PBYI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Puma Biotechnology's (PBYI) Q1 Earnings and Revenues Beat
Puma Biotech (PBYI) Reports Q1 Loss, Tops Revenue Estimates
What's in Store for Puma Biotechnology (PBYI) in Q1 Earnings?
Other News for PBYI
Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial Results
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotechnology Stockholders Elect Leadership and Approve Amendments
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Beyond The Numbers: 4 Analysts Discuss Puma Biotechnology Stock